Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Amaral

Showing results (221-230 of 288) with videos related to

Pageof 29
Sort By:
Molecular and Cellular Biology|September 21, 2011
Contribution of casein kinase 2 and spleen tyrosine kinase to CFTR trafficking and protein kinase A-induced activitySimão Luz, Patthara Kongsuphol, Ana Isabel Mendes, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Analysis of genomic CFTR DNAClaude Férec, Cédric Le Maréchal, Marie-Pierre Audrézet, et al.
The Biochemical Journal|October 17, 2012
CFTR mutations altering CFTR fragmentationKendra Tosoni, Michelle Stobbart, Diane M Cassidy, et al.
British Journal of Pharmacology|September 6, 2012
Control of TMEM16A by INO-4995 and other inositolphosphatesYuemin Tian, Rainer Schreiber, Podchanart Wanitchakool, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 22, 2018
R560S: A class II CFTR mutation that is not rescued by current modulatorsNikhil T Awatade, Sofia Ramalho, Iris A L Silva, et al.
Molecular Diagnosis & Therapy|September 13, 2025
Personalized Medicine in Cystic Fibrosis: Characterization of Eight Rare CFTR Variants in Intestinal Organoids and Cellular ModelsVioleta Railean, Cláudia S Rodrigues, Ines Pankonien, et al.
Cell Death Discovery|August 1, 2018
Phenotypic screening identifies a new oxazolone inhibitor of necroptosis and neuroinflammationSara R Oliveira, Pedro A Dionísio, Hugo Brito, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|November 21, 2017
A novel microscopy-based assay identifies extended synaptotagmin-1 (ESYT1) as a positive regulator of anoctamin 1 trafficJoana R Lérias, Madalena C Pinto, Hugo M Botelho, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 16, 2019
Speeding up access to new drugs for CF: Considerations for clinical trial design and deliveryJane C Davies, Pavel Drevinek, J Stuart Elborn, et al.
Journal of Clinical Medicine|September 13, 2025
Comparison of the Effect of CFTR Modulators <i>elexacaftor</i>/<i>tezacaftor</i>/<i>ivacaftor</i> and <i>lumacaftor</i>/<i>ivacaftor</i> via Serum Human Epididymis Protein 4 Concentration in <i>p.Phe508del-CFTR</i> Homozygous Cystic Fibrosis PatientsMarianna Pócsi, Libor Fila, Csaba Péterfia, et al.
Pageof 29

Showing results (221-230 of 288) with videos related to

Sort By:
Pageof 29
Molecular and Cellular Biology|September 21, 2011
Contribution of casein kinase 2 and spleen tyrosine kinase to CFTR trafficking and protein kinase A-induced activitySimão Luz, Patthara Kongsuphol, Ana Isabel Mendes, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Analysis of genomic CFTR DNAClaude Férec, Cédric Le Maréchal, Marie-Pierre Audrézet, et al.
The Biochemical Journal|October 17, 2012
CFTR mutations altering CFTR fragmentationKendra Tosoni, Michelle Stobbart, Diane M Cassidy, et al.
British Journal of Pharmacology|September 6, 2012
Control of TMEM16A by INO-4995 and other inositolphosphatesYuemin Tian, Rainer Schreiber, Podchanart Wanitchakool, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 22, 2018
R560S: A class II CFTR mutation that is not rescued by current modulatorsNikhil T Awatade, Sofia Ramalho, Iris A L Silva, et al.
Molecular Diagnosis & Therapy|September 13, 2025
Personalized Medicine in Cystic Fibrosis: Characterization of Eight Rare CFTR Variants in Intestinal Organoids and Cellular ModelsVioleta Railean, Cláudia S Rodrigues, Ines Pankonien, et al.
Cell Death Discovery|August 1, 2018
Phenotypic screening identifies a new oxazolone inhibitor of necroptosis and neuroinflammationSara R Oliveira, Pedro A Dionísio, Hugo Brito, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|November 21, 2017
A novel microscopy-based assay identifies extended synaptotagmin-1 (ESYT1) as a positive regulator of anoctamin 1 trafficJoana R Lérias, Madalena C Pinto, Hugo M Botelho, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 16, 2019
Speeding up access to new drugs for CF: Considerations for clinical trial design and deliveryJane C Davies, Pavel Drevinek, J Stuart Elborn, et al.
Journal of Clinical Medicine|September 13, 2025
Comparison of the Effect of CFTR Modulators <i>elexacaftor</i>/<i>tezacaftor</i>/<i>ivacaftor</i> and <i>lumacaftor</i>/<i>ivacaftor</i> via Serum Human Epididymis Protein 4 Concentration in <i>p.Phe508del-CFTR</i> Homozygous Cystic Fibrosis PatientsMarianna Pócsi, Libor Fila, Csaba Péterfia, et al.
Pageof 29